Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Nov 15, 2008 (Vol. 28, No. 20)

Gallery

URL:www.myco-vaud.ch/gallery
  • Communications options
  • Too little information
If I spoke French, I’d undoubtedly be in a better position to critique this very beautiful website devoted to mushrooms. Fortunately, pictures speak a universal language, and it is a most beautiful one. Eric Strauss appears to be the organizer of this visually enriched site. Every page of the site overflows with (sometimes) stunning photographs of mushrooms in their native environment. Content from the site can be downloaded for import to Excel files. Other materials include links to page upon page of more pictures. I don’t see much educational content at the site except for the pictures, and that aspect of the site could be updated, and would likely result in increased traffic.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good


*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »